These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
724 related articles for article (PubMed ID: 7565543)
81. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Stansell JD; Osmond DH; Charlebois E; LaVange L; Wallace JM; Alexander BV; Glassroth J; Kvale PA; Rosen MJ; Reichman LB; Turner JR; Hopewell PC Am J Respir Crit Care Med; 1997 Jan; 155(1):60-6. PubMed ID: 9001290 [TBL] [Abstract][Full Text] [Related]
82. Discontinuing prophylaxis against Pneumocystis carinii pneumonia. Le Moal G; Breux JP; Roblot F N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363 [No Abstract] [Full Text] [Related]
83. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus. Phair JP; Masur H; Gross PA; Holmes KK; Kaplan JE Clin Infect Dis; 1995 Aug; 21 Suppl 1():S128-9. PubMed ID: 8547504 [No Abstract] [Full Text] [Related]
84. Pneumocystis carinii pneumonia in children with perinatally acquired HIV infection. Meyers A JAMA; 1994 Jan; 271(2):103. PubMed ID: 8264060 [No Abstract] [Full Text] [Related]
85. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Green H; Paul M; Vidal L; Leibovici L Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871 [TBL] [Abstract][Full Text] [Related]
86. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing? Miller RF Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633 [No Abstract] [Full Text] [Related]
87. Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent selective immune reconstitution after initiation of antiretroviral therapy. Crothers K; Huang L HIV Med; 2003 Oct; 4(4):346-9. PubMed ID: 14525547 [TBL] [Abstract][Full Text] [Related]
88. Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients. Lin X; Garg S; Mattson CL; Luo Q; Skarbinski J J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):455-458. PubMed ID: 27629868 [TBL] [Abstract][Full Text] [Related]
89. [Severe bacterial infections after prophylactic suppression of Pneumocystis carinii in HIV infected patients after CD4 lymphocyte recovery]. Boix V; Murcia JM; Merino E; Portilla J Med Clin (Barc); 2002 Jun; 118(20):796-7. PubMed ID: 12049699 [No Abstract] [Full Text] [Related]
91. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection. J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):46-55. PubMed ID: 8417174 [No Abstract] [Full Text] [Related]
92. Efficacy and safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children. Stavola JJ; Noel GJ Pediatr Infect Dis J; 1993 Aug; 12(8):644-7. PubMed ID: 8414776 [TBL] [Abstract][Full Text] [Related]
93. Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina. Fallo AA; DobrzanskiNisiewicz W; Sordelli N; Cattaneo MA; Scott G; López EL Int J Infect Dis; 2002 Mar; 6(1):9-16. PubMed ID: 12044295 [TBL] [Abstract][Full Text] [Related]
94. Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium. Abrams EJ; Weedon J; Bertolli J; Bornschlegel K; Cervia J; Mendez H; Lambert G; Singh T; Thomas P; Pediatr Infect Dis J; 2001 May; 20(5):511-7. PubMed ID: 11368109 [TBL] [Abstract][Full Text] [Related]
95. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Green H; Paul M; Vidal L; Leibovici L Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808 [TBL] [Abstract][Full Text] [Related]
96. Pneumocystis pneumonia in South African children diagnosed by molecular methods. Morrow BM; Samuel CM; Zampoli M; Whitelaw A; Zar HJ BMC Res Notes; 2014 Jan; 7():26. PubMed ID: 24410938 [TBL] [Abstract][Full Text] [Related]
97. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients. Held M; Goebel FD Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444 [No Abstract] [Full Text] [Related]
98. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108 [TBL] [Abstract][Full Text] [Related]
99. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group. McIntosh K; Cooper E; Xu J; Mirochnick M; Lindsey J; Jacobus D; Mofenson L; Yogev R; Spector SA; Sullivan JL; Sacks H; Kovacs A; Nachman S; Sleasman J; Bonagura V; McNamara J Pediatr Infect Dis J; 1999 May; 18(5):432-9. PubMed ID: 10353516 [TBL] [Abstract][Full Text] [Related]
100. Pneumocystis carinii pneumonia in infants who were exposed to human immunodeficiency virus but were not infected: an exception to the AIDS surveillance case definition. Heresi GP; Caceres E; Atkins JT; Reuben J; Doyle M Clin Infect Dis; 1997 Sep; 25(3):739-40. PubMed ID: 9314473 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]